TransMedics Group, Inc. (TMDX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.14B |
| Enterprise Value | 4.12B |
| P/E Ratio | 15.01 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 4.1 |
| Price/Book Ratio | 5.26 |
| Enterprise/Revenue | 4.74 |
| Enterprise/EBITDA | 21.55 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.27 |
| Operating Margin | 0.15 |
| Return On Assets | 0.12 |
| Return On Equity | 0.42 |
| Revenue | 605.49M |
| Revenue/Share | 18.49 |
| Gross Profit | 362.81M |
| EBITDA | 148.49M |
| Net Income | 190.29M |
| Diluted EPS | 4.87 |
| Total Cash | 461.74M |
| Total Cash/Share | 13.43 |
| Total Debt | 863.42M |
| Total Debt/Equity | 1.75 |
| Current Ratio | 6.74 |
| Book Value Per Share | 14.37 |
| 52-Week Change | -40.79 |
| 52-Week High | 156 |
| 52-Week Low | 60.11 |
| Moving Average 50 Days | 84.37 |
| Moving Average 200 Days | 115.05 |
| Average Volume | 1.31M |
| Shares Outstanding | 34.56M |
| % Held by Institutions | 106.49 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |